The boomerang kid: Nucelis moves back home as parent company, Cibus, acquires remaining interest

In a surprising announcement on January 6, 2014, Cibus announced it had acquired the remaining interest in its spinout, Nucelis. Just over a year and a half ago, Nucelis became an independent entity from parent company Cibus, though it was incorporated prior to that in December 2010, and was esta...

This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

Nature-inspired herbicide discovery startup FortePhest raises undisclosed Series B funds

News Commentary | February 15, 2022

Israeli biotech startup FortePhest will use funds from a round led by BASF Venture Capital and Orbia Ventures to accelerate pipeline development to meet regulatory requirements and commercialize products. FortePhest is developing several herbicides using a noncoded amino acid, meta‑tyrosine. This ... Not part of subscription

NuCicer raises USD 4.5 million to commercialize high-protein chickpea variety

News Commentary | March 09, 2022

Plant genetics startup NuCicer announced a USD 4.5 million fundng round led by Lever VC. The University of California – Davis spinout controls significant chickpea genetics and has developed a trait that increases protein content by 75%. The funds will be used for commercialization trials and ... Not part of subscription

Marrone Bio Innovation merging with Bioceres Crop Solutions is an smart strategy for biological product portfolio expansion

Case Study | May 12, 2022

In March 2022, Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (Bioceres) and Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI) announced that they would merge in an all‑stock transaction. Bioceres also recently acquired Rizobacter, an established biological and chemical solutions platform for crop ... Not part of subscription